DEADLINE ALERT for RIDE, BHC, SYNH, and T: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
August 04, 2023 11:06 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Aug. 04, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
Syneos Health Stockholders Approve Agreement with Private Investment Consortium
August 02, 2023 08:47 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organization, today...
Moore Kuehn Encourages SYNH, SPPI, ARNC and EMBK Investors to Contact Law Firm
July 03, 2023 11:37 ET
|
Moore Kuehn
NEW YORK, July 03, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
Syneos Health Reports First Quarter 2023 Results
May 10, 2023 07:07 ET
|
Syneos Health, Inc.
Revenue for the first quarter of $1,356.8 million increased 1.5% on a reported basis and increased 2.4% on a constant currency basis year-over-year.Clinical Solutions net new business awards and...
Syneos Health to be Acquired by a Private Investment Consortium for Approximately $7.1 Billion
May 10, 2023 06:47 ET
|
Syneos Health, Inc.
Shareholders to Receive $43.00 Per Share in Cash Represents 24% Premium to Unaffected Stock Price MORRISVILLE, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos...
Syneos Health Appoints Michael Bonello as Chief Financial Officer
May 02, 2023 06:19 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 02, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Michael...
Syneos Health Schedules Fourth Quarter and Full Year 2022 Earnings Call for Thursday, February 16th, 2023
February 08, 2023 21:41 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and full year...
Syneos Health Announces Partnership with Fosun Pharma USA to Launch Serplulimab
January 11, 2023 07:10 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with...
Syneos Health to Participate in Fireside Chat at the 2022 Evercore ISI HealthCONx Conference
November 17, 2022 16:44 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer...
Syneos Health Adds HUB Patient Suite to Deployment Solutions Business
October 27, 2022 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it is introducing a dedicated...